| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2380078C Combination therapy using pentafluorobenzenesulfonamides |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2368370C The use of dienogest in high dosages |
| 05/06/2008 | CA2327468C Semi-synthetic ecteinascidins |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/02/2008 | WO2008052187A2 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | WO2008052005A2 Compounds and methods for treating estrogen receptor-related diseases |
| 05/02/2008 | WO2008051826A2 Purines as pkc-theta inhibitors |
| 05/02/2008 | WO2008051808A2 Bicyclic triazoles as protein kinase modulators |
| 05/02/2008 | WO2008051763A1 Cathepsin proteases inhibitors |
| 05/02/2008 | WO2008051547A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | WO2008051531A2 Discontinuous methods of treating cancer |
| 05/02/2008 | WO2008051525A2 Methods of treating ovarian cancer |
| 05/02/2008 | WO2008051523A2 Carbazole derivatives useful as medicaments in cancer therapy |
| 05/02/2008 | WO2008051494A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 05/02/2008 | WO2008051493A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 05/02/2008 | WO2008051465A2 Process for making crystalline anhydrous docetaxel |
| 05/02/2008 | WO2008051291A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/02/2008 | WO2008051220A1 Interaction of il-27 and il-2 for treatment of tumors |
| 05/02/2008 | WO2008050962A1 Composition for in vivo transplantation for treatment of human cervical cancer comprising mononuclear cells derived from umbilical cord blood |
| 05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050707A1 Pharmaceutical agent and extract for use in the pharmaceutical |
| 05/02/2008 | WO2008050125A1 Compounds and uses thereof |
| 05/02/2008 | WO2008050096A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 05/02/2008 | WO2008050078A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 05/02/2008 | WO2008049997A2 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | WO2008049996A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/02/2008 | WO2008049990A2 Use of an anti-cd151 antibody in the treatment of cancer |
| 05/02/2008 | WO2008049904A2 Use of mtki 1 for treating or preventing bone cancer |
| 05/02/2008 | WO2008049901A1 Use of a mt kinase inhibitor for treating or preventing brain cancer |
| 05/02/2008 | WO2008049855A2 7-azaindole derivatives as c-met kinase inhibitors |
| 05/02/2008 | WO2008049832A1 Furanone derivatives as cysteine protease inhibitors |
| 05/02/2008 | WO2008049644A1 Thymidine analogs for imaging |
| 05/02/2008 | WO2008049643A2 Gd2 peptide mimotopes for anticancer vaccination |
| 05/02/2008 | WO2008049605A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2008 | WO2008049329A1 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 05/02/2008 | WO2008049231A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 05/02/2008 | WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 05/02/2008 | WO2008028934A8 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 05/02/2008 | WO2008019326A3 Ephb3-specific antibody and uses thereof |
| 05/02/2008 | WO2008014410A3 Zimlig2 polynucleotides and polypeptides and methods of use |
| 05/02/2008 | WO2008010098A3 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 05/02/2008 | WO2008006720A3 Crystalline nemorubicin hydrochloride |
| 05/02/2008 | WO2008002676A3 Biaryl compositions and methods for modulating a kinase cascade |
| 05/02/2008 | WO2007149932A3 Methods and compositions for targeting hepsin |
| 05/02/2008 | WO2007144503A3 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained |
| 05/02/2008 | WO2007135293A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 05/02/2008 | WO2007131737A3 Medication against breast cancer and related diseases |
| 05/02/2008 | WO2007130697A8 Anti-ephb4 antibodies and methods using same |
| 05/02/2008 | WO2007093975A3 Use of the pedf factor to induce cell regeneration |
| 05/02/2008 | CA2669111A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors |
| 05/02/2008 | CA2667816A1 Compositions and methods for inhibiting cathepsin proteases |
| 05/02/2008 | CA2667453A1 Triazolo-pyridazine protein kinase modulators |
| 05/02/2008 | CA2667428A1 Bicyclic triazoles as protein kinase modulators |
| 05/02/2008 | CA2667363A1 Discontinuous methods of treating cancer |
| 05/02/2008 | CA2667362A1 Methods of treating ovarian cancer |
| 05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | CA2667231A1 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | CA2667019A1 Antibodies and immunoconjugates and uses therefor |
| 05/02/2008 | CA2666940A1 Purines as pkc-theta inhibitors |
| 05/02/2008 | CA2666885A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2008 | CA2666672A1 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/02/2008 | CA2666624A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 05/02/2008 | CA2666618A1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 05/02/2008 | CA2666606A1 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 05/02/2008 | CA2666497A1 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | CA2665912A1 Use of an anti-cd151 antibody in the treatment of cancer |
| 05/02/2008 | CA2665736A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer |
| 05/02/2008 | CA2664165A1 Use of mtki 1 for treating or preventing bone cancer |
| 05/02/2008 | CA2664148A1 Vegfr3 inhibitors |
| 05/02/2008 | CA2664145A1 Use of a mt kinase inhibitor for treating or preventing brain cancer |
| 05/02/2008 | CA2664115A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/02/2008 | CA2663536A1 Materials and methods for improved immunoglycoproteins |
| 05/01/2008 | US20080103320 Total Synthesis of Myriaporones |
| 05/01/2008 | US20080103215 Screening Method |
| 05/01/2008 | US20080103195 Compounds from antrodia camphorata for inhibiting the growth of cancer tumor cells |
| 05/01/2008 | US20080103192 Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer |
| 05/01/2008 | US20080103188 Novel bicyclic compounds as modulators of androgen receptor function |
| 05/01/2008 | US20080103160 Of Src homology protein tyrosine phosphatase 1; phenyl isothiazolones or a benzo-1,4-quinone; antineoplastic agents; immunostimulants inducing a cytokine response; side effect reduction |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103136 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle |
| 05/01/2008 | US20080103131 Therapeutically Active Thiophenepyrimidinone Compounds and Their Use |
| 05/01/2008 | US20080103129 Heterocyclic derived metalloprotease inhibitors |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080103112 pressurizing deoxygenated suspension of particules and acetic acid and heating to form soluble material; higher dosage, reduced side effects; immunostimulants |
| 05/01/2008 | US20080103110 Water soluble prodrugs comprising therapeutics coupled via metabolically cleavable ester bond to proteins; extended blood half life; cancer, inflammation, infection, pain |
| 05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
| 05/01/2008 | US20080103104 Benzamide precursor with sulfur substituent; poly-ADP-ribose polymerase inhibitors, antitumor agents; leukemia, breast, ovarian, lung, bladder, prostate, pancreatic, and cervical cancers |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080103095 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |